down arrow

Ind-Swift Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE915B01019
  • NSEID: INDSWFTLAB
  • BSEID: 532305
INR
84.36
1.96 (2.38%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 1.01 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

84.0086.00

52 Week

74.00186.00
Valuation
Technical
Day's Volume

CASH

1.01 lacs (47.66%) Volume

Shareholding (Mar 2025)

FII

3.00%

Held by 5 FIIs

DII

0.91%

Held by 0 DIIs

Promoter

40.94%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.81 times
  • The company has been able to generate a Return on Equity (avg) of 5.41% signifying low profitability per unit of shareholders funds
2

With a fall in Net Sales of -96.99%, the company declared Very Negative results in Dec 24

3

Stock is technically in a Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 496 Cr (Micro Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.45

stock-summary
Return on Equity

10.04%

stock-summary
Price to Book

0.52

Revenue and Profits (1 Year):
Net Sales:
9 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-25.01%
0%
-25.01%
1 Year
-32.98%
0%
-32.98%
2 Years
32.27%
0%
32.27%
3 Years
16.28%
0%
16.28%
4 Years
11.0%
0%
11.0%
5 Years
243.63%
0%
243.63%

Latest dividend: 1 per share ex-dividend date: Sep-20-2011

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-10.46%
EBIT Growth (5y)
-3.25%
EBIT to Interest (avg)
0.56
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.35
Tax Ratio
27.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.92%
ROCE (avg)
38.92%
ROE (avg)
5.41%
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
33
Price to Book Value
0.52
EV to EBIT
2.64
EV to EBITDA
1.77
EV to Capital Employed
0.14
EV to Sales
0.16
PEG Ratio
1.07
Dividend Yield
NA
ROCE (Latest)
15.49%
ROE (Latest)
10.04%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 5 FIIs (3.0%)

Promoter with highest holding

Essix Biosciences Limited (36.83%)

Highest Public shareholder

Wilson Holdings Private Limited (8.74%)

Individual Investors Holdings

37.77%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -96.99% vs -8.05% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -99.95% vs -29.38% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.66",
          "val2": "287.51",
          "chgp": "-96.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-14.53",
          "val2": "51.69",
          "chgp": "-128.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.11",
          "val2": "21.05",
          "chgp": "-99.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.01",
          "val2": "19.42",
          "chgp": "-99.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-167.78%",
          "val2": "17.98%",
          "chgp": "-185.76%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -92.48% vs 1.64% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -97.24% vs 8.14% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45.12",
          "val2": "600.05",
          "chgp": "-92.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-21.53",
          "val2": "125.99",
          "chgp": "-117.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.58",
          "val2": "41.52",
          "chgp": "-98.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.35",
          "val2": "48.90",
          "chgp": "-97.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-47.72%",
          "val2": "21.00%",
          "chgp": "-68.72%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -93.94% vs -1.72% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -98.01% vs -6.05% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "53.78",
          "val2": "887.56",
          "chgp": "-93.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-36.06",
          "val2": "177.68",
          "chgp": "-120.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.69",
          "val2": "62.57",
          "chgp": "-98.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.36",
          "val2": "68.32",
          "chgp": "-98.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-67.05%",
          "val2": "20.02%",
          "chgp": "-87.07%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 6.10% vs 16.23% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 784.37% vs 2,313.95% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,280.90",
          "val2": "1,207.31",
          "chgp": "6.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "254.20",
          "val2": "229.20",
          "chgp": "10.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "51.10",
          "val2": "92.17",
          "chgp": "-44.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "386.59",
          "val2": "-26.65",
          "chgp": "1,550.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "420.96",
          "val2": "47.60",
          "chgp": "784.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.85%",
          "val2": "18.98%",
          "chgp": "0.87%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
8.66
287.51
-96.99%
Operating Profit (PBDIT) excl Other Income
-14.53
51.69
-128.11%
Interest
0.11
21.05
-99.48%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.01
19.42
-99.95%
Operating Profit Margin (Excl OI)
-167.78%
17.98%
-185.76%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is -96.99% vs -8.05% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -99.95% vs -29.38% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
45.12
600.05
-92.48%
Operating Profit (PBDIT) excl Other Income
-21.53
125.99
-117.09%
Interest
0.58
41.52
-98.60%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.35
48.90
-97.24%
Operating Profit Margin (Excl OI)
-47.72%
21.00%
-68.72%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -92.48% vs 1.64% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -97.24% vs 8.14% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
53.78
887.56
-93.94%
Operating Profit (PBDIT) excl Other Income
-36.06
177.68
-120.29%
Interest
0.69
62.57
-98.90%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.36
68.32
-98.01%
Operating Profit Margin (Excl OI)
-67.05%
20.02%
-87.07%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -93.94% vs -1.72% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -98.01% vs -6.05% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,280.90
1,207.31
6.10%
Operating Profit (PBDIT) excl Other Income
254.20
229.20
10.91%
Interest
51.10
92.17
-44.56%
Exceptional Items
386.59
-26.65
1,550.62%
Consolidate Net Profit
420.96
47.60
784.37%
Operating Profit Margin (Excl OI)
19.85%
18.98%
0.87%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 6.10% vs 16.23% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 784.37% vs 2,313.95% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Ind-Swift Laboratories Ltd stock-summary
stock-summary
Ind-Swift Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Ind-Swift Laboratories Limited is a part of the Ind-Swift Group and is based at Chandigarh, India. The Company is one of the leading manufacturers of APIs catering to global and domestic formulators. Based in Chandigarh, India, the Company operated two advanced manufacturing facilities in Derabassi and Jammu, adhering to international standards. Ind-Swift Laboratories Ltd.
Company Coordinates stock-summary
Company Details
SCO 850 Shivalik Enclave, NAC Manimajra Chandigarh Chandigarh ( U T ) : 160101
stock-summary
Tel: 91-0172-5061850/2730920
stock-summary
http://www.indswiftlabs.com
stock-summary
investor@indswiftlabs.com
Registrar Details
Alankit Assignments Ltd , 205-208 , Anarkali Complex, Jhandewala Extension, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."